National Disease Research Interchange
National Disease Research Interchange
National Disease Research Interchange
National Disease Research Interchange
National Disease Research Interchange
National Disease Research Interchange
National Disease Research Interchange
Every year, NDRI distributes biospecimens to hundreds of investigators around the world who are working to advance many areas of science and healthcare. NDRI makes it easy for approved investigators to get much-needed biospecimens prepared, preserved and shipped precisely according the specific needs of the research protocol.
Request Process Request TissueResearchers continue to recognize NDRI as an invaluable partner as the need for human biomaterials grow. In response, NDRI has developed specialized programs to increase the supply of human tissues and organs for specific areas of research and has established a network of human tissue collection sites throughout the country to procure them.
Become a Partner See Our ProgramsNDRI has been accepted as a participant in the poster session at the Society for Neuroscience 2019 annual conference in Chicago, IL from October 19-23. We will be presenting on advancing Alzheimer's disease and related dementias research via a multi-pronged human biospecimens collection initiatives.
The Accreditation Committee of the College of American Pathologists (CAP) awarded accreditation the biorepository of the National Disease Research Interchange (NDRI) in Philadelphia, PA based on results of a recent on-site inspection as part of the CAP’s Accreditation Programs. NDRI was first accredited by CAP in 2016. Accreditations occur every three years.
Congratulations to The Center for Organ Recovery and Education, otherwise known as CORE, as the recipient of the inaugural NDRI/AOPO Empowering Research and Discovery Award for Outstanding commitment to the advancement of research.
Robert (Bob) Zipperlen, CPA joined NDRI in the spring of 2019 as the Vice President of Administration & CFO.
Loading tweets...
NDRI is a Not-For-Profit (501c3) Corporation.